Share This Page

Medical device manufacturer selects W.Pa. for new plant

| Tuesday, Nov. 27, 2012, 5:40 p.m.

A fast-growing manufacturer of components for medical devices and surgical instruments is expanding its business with a new operation in Cranberry.

Cadence Inc., based in Staunton, Va., said it will build a “clean-room” assembly area in leased space in the Cranberry Business Park.

The facility is expected to open during the first quarter next year and eventually employ about 60 workers. With special air-handling equipment and procedures, a clean room is used to assemble and package sterilized medical equipment.

“Pittsburgh was chosen for Cadence's newest facility because of the availability of employees with specialized medical device knowledge and experience,” the privately held contract-manufacturing company said in a statement.

Initially, Cadence will do work for existing customers in other parts of the country, President Alan Connor said. But with Pittsburgh's growing base of medical device companies, Connor said he expects the company to eventually win work for local companies.

“It's good to have another supplier here,” said John Manzetti, CEO of the Pittsburgh Life Sciences Greenhouse, a South Side organization that provides money and startup assistance for local medical companies.

Western Pennsylvania has a large number of entrepreneurs commercializing new medical devices, Manzetti said, noting that “more than half of the 70 some companies we've funded are medical device companies.”

Connor, who was born in Pittsburgh and earned an MBA from University of Pittsburgh, worked for Marshall-based Medrad for 10 years before moving to Virginia. Medrad is a medical imaging company and subsidiary of Bayer Corp. in Robinson.

Cadence, which has manufacturing facilities in Rhode Island and Virginia, has increased revenue by 74 percent in the past three years and is adding the clean-room assembly capability to better serve its customers, Connor said.

“Medical device customers are looking to consolidate their supply chains around their most critical and trusted suppliers,” he said.

Connor said he has hired four people for the Cranberry operation so far, including its general manager Marc Mabie.

Alex Nixon is a staff writer for Trib Total Media. He can be reached at 412-320-7928 or anixon@tribweb.com.

TribLIVE commenting policy

You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.